Zepatier® (elbasvir/grazoprevir) has been approved by the FDA and is now available on the web, app and printable versions of the interaction charts.
The recommendations in the charts are based on information provided in the US Prescribing Information. The charts will be updated to include the European product label when EMA approval has been granted and the label is available.
